Report overview
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines. This report contains market size and forecasts of Dengue Vaccines in global, including the following market information:
Global Dengue Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dengue Vaccines market was valued at US$ 412.2 million in 2022 and is projected to reach US$ 1010.9 million by 2029, at a CAGR of 13.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
We surveyed the Dengue Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dengue Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Type, 2022 (%)
Dengvaxia
TAK-003
Others
Global Dengue Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Application, 2022 (%)
Public Sector
Private Sector
Global Dengue Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dengue Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dengue Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dengue Vaccines, market overview.
Chapter 2: Global Dengue Vaccines market size in revenue.
Chapter 3: Detailed analysis of Dengue Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dengue Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
